Ronesans Gayrimenkul Yatirim A.S. (IST:RGYAS)

Market Cap	44.55B
Revenue (ttm)	8.10B
Net Income (ttm)	673.10M
Shares Out	331.00M
EPS (ttm)	2.06
PE Ratio	65.28
Forward PE	2.58
Dividend	n/a
Ex-Dividend Date	n/a

Volume	275,636
Average Volume	578,370
Open	134.80
Previous Close	134.40
Day's Range	133.30 - 135.20
52-Week Range	93.75 - 144.50
Beta	n/a
RSI	47.48
Earnings Date	Aug 19, 2025

About Ligand Pharmaceuticals

Ronesans Gayrimenkul Yatirim A.S., together with its subsidiaries, operates as the commercial real estate development and investment company in Türkiye. The company develops and manages shopping malls, office buildings, and other commercial real estate projects, as well as residential properties; It also provides management and consulting, and asset management services, as well as rents investment properties. The company was founded in 2006 and is headquartered in Ankara, Türkiye. Ronesans Gayrimenkul Yatirim A.S. operates as a subsidiary of Ro...

• Industry: Real Estate - Development
• Sector: Real Estate
• Founded: 2006
• Employees: 318
• Stock Exchange: Istanbul Stock Exchange
• Ticker Symbol: RGYAS

Financial Performance

In 2024, IST:RGYAS's revenue was 8.36 billion, a decrease of -19.95% compared to the previous year's 10.44 billion. Earnings were 4.69 billion, a decrease of -82.25%.